Myto Therapeutics
Company

Myto Therapeutics

Biotechnology Research Davis, Ca, United States 2 employees
Employees
2
Contacts
1
Emails
1

Myto Therapeutics Overview

Headquarters
Davis, Ca, United States
Industry
Biotechnology Research
Employees
2
Founded
2021
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Myto Therapeutics

Myto Therapeutics develops novel small-molecules that ameliorate orphan mitochondrial diseases, including Friedreich's ataxia and Leigh Syndrome. Our patented technology delivers bioactive monomethyl fumarate molecules with superior pharmacokinetics (PK) to other marketed prodrugs. The superior PK of our molecules underlies their greater pharmacodynamic potency to ameliorate mitochondrial diseases. The Mechanism of Action of our MYT-109 suggests it is a 'platform' drug, which could treat multiple mitochondrial diseases.

Myto Therapeutics Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

Myto Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Zane Starkewolfe Enabling Biotech Innovation
Email

Compare Similar Companies to Myto Therapeutics